Why do women discontinue contraception and what are the post-discontinuation outcomes? Evidence from the Arusha Region, Tanzania.
Adolescent
Adult
Condoms
Contraception
/ methods
Contraception Behavior
/ ethnology
Contraceptive Agents, Female
/ administration & dosage
Family Planning Services
/ organization & administration
Female
Health Services Accessibility
Humans
Patient Compliance
/ ethnology
Pregnancy
Pregnancy, Unplanned
Pregnancy, Unwanted
Surveys and Questionnaires
Young Adult
Tanzania
continuation of contraceptive use
determinants of discontinuation
post-discontinuation reproductive behaviours
side effects
Journal
Sexual and reproductive health matters
ISSN: 2641-0397
Titre abrégé: Sex Reprod Health Matters
Pays: England
ID NLM: 101743493
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
entrez:
18
3
2020
pubmed:
18
3
2020
medline:
9
4
2020
Statut:
ppublish
Résumé
In Africa, high discontinuation of contraceptive use is thwarting goals for healthy birth spacing or limiting childbearing. This paper investigates how well the contraception program is addressing the needs of women and couples in the Arusha region, Tanzania by studying contraceptive use continuation. We measured the overall and method-specific discontinuation rate, reasons for discontinuation, post-discontinuation reproductive behaviours/outcomes, and examined the determinants of contraceptive discontinuation. We used data from a household survey conducted in Arusha from January to May 2018. Information on contraceptive use during the 31 months preceding the survey was recorded in a monthly calendar. Using the single- and multiple-decrement life-table approach, we calculated the overall and cause-specific discontinuation of contraceptive methods. Logistic regression was used to evaluate the determinants of discontinuation. The 12-month overall discontinuation of contraceptive use was 44.6%. Discontinuation was lowest for implants (12.3%) and highest for male condoms (60.1%), the most common reason being side effects (11.7%). 59.8% of women who discontinued did not switch to another method within 3 months following discontinuation and 20.9% experienced pregnancy. Longer distance to a health facility is associated with higher discontinuation of hormonal methods such as injectables, but lower discontinuation of non-hormonal methods such as condoms. Discontinuation due to side effects is not explained by most of the women's background characteristics other than the method they used. Discontinuation of contraception is high among Arusha women. Effective contraception programs, especially improved counselling, need to address the reasons for the discontinuation of contraceptive use.
Identifiants
pubmed: 32178594
doi: 10.1080/26410397.2020.1723321
pmc: PMC7888019
doi:
Substances chimiques
Contraceptive Agents, Female
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1723321Références
Lancet Glob Health. 2018 Apr;6(4):e380-e389
pubmed: 29519649
Reprod Health. 2017 Apr 27;14(1):56
pubmed: 28449723
Int Perspect Sex Reprod Health. 2013 Sep;39(3):133-41
pubmed: 24135045
PLoS One. 2017 Nov 13;12(11):e0187311
pubmed: 29131860
Bull World Health Organ. 2011 Feb 1;89(2):137-43
pubmed: 21346925
Reprod Health. 2017 Oct 17;14(1):130
pubmed: 29041936
Popul Dev Rev. 2017 May;43(Suppl Suppl 1):166-191
pubmed: 29081552
Lancet Glob Health. 2015 Jul;3(7):e366-77
pubmed: 25999096
Am J Obstet Gynecol. 1998 Sep;179(3 Pt 1):577-82
pubmed: 9757954
Lancet. 2016 Jun 11;387(10036):2423-78
pubmed: 27174304
BMC Womens Health. 2015 Nov 03;15:97
pubmed: 26530029